FGF21 and metabolic dysfunction-associated steatotic liver disease: We validated key results with an independent hiPSC-Hep line with a different genetic background, showing similar lipid accumulation and gene expression levels for the NAFLD biomarker, FGF21, in the presence of FA and TG cocktail.